Predoctoral Training Program in Molecular Pharmacology

分子药理学博士前培训项目

• 批准号: 7107996
• 负责人: MATTHEW M AMES
• 金额: $ 17.65万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-08-10 至 2010-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7107996
• 关键词: Predoctoral; Training; Program; Molecular; Pharmacology

DESCRIPTION (provided by applicant): The primary goal of the Ph.D. Training Program in Molecular Pharmacology and Experimental Therapeutics (MPET) in the Mayo Graduate School is the development of independent investigators capable of directing outstanding research Programs in academia, industry or other settings. The faculty is comprised of 18 well funded, independent investigators, who focus on a continuum of research encompassing studies from basic molecular and genetic aspects of disease through drug discovery and development of novel therapies for cardiovascular, neurodegenerative and malignant diseases. This faculty provides training opportunities in areas that include computational chemistry, molecular mechanisms of drug action and resistance, novel therapeutic strategies, preclinical and clinical pharmacology, and pharmacogenomics of genes associated with drug responses. Twenty-one predoctoral students are currently enrolled in the MPET track of the Biomedical Sciences Ph.D. Program. A rigorous didactic curriculum includes a series of Core Curriculum courses that ensures a strong fundamental knowledge in biochemistry, molecular biology, genetics, statistics, cell biology and pharmacology and a series of tutorial-based courses to provide students with advanced training in molecular pharmacology. During their first two years of study, students complete 3 laboratory rotations and select a laboratory for their thesis research. They sit for comprehensive written and oral qualifying examinations at the end of year two. After developing a thesis written proposal delineating the questions and approaches to be pursued in the thesis research, the thesis committee reviews the proposed research at the first committee meeting. Students present work-in-progress updates on their research projects to MPET faculty and students each year. Students are strongly encouraged to publish completed work in a timely manner and to attend national meetings to present their work. The average time to completion of the Ph.D. Program is approximately 4.8 years. During the fourth and fifth years of training, students are mentored to identify outstanding postdoctoral training opportunities as the next step in their career development. Graduates of the MPET Ph.D. training program have outstanding track records, with many now serving as principal investigators directing their own laboratories.

描述(由申请人提供)：梅奥研究生院分子药理学和实验治疗(MPET)博士培训计划的主要目标是培养能够指导学术界、工业界或其他领域杰出研究项目的独立研究人员。该学院由18名资金充足的独立研究人员组成，他们专注于一系列研究，包括从疾病的基本分子和遗传方面的研究，通过药物发现和心血管、神经退行性疾病和恶性疾病的新疗法的开发。该学院提供的培训领域包括计算化学、药物作用和耐药性的分子机制、新的治疗策略、临床前和临床药理学，以及与药物反应相关的基因的药物基因组学。21名博士前学生目前在生物医学科学博士项目的MPET轨道上注册。严格的教学课程包括一系列核心课程，以确保在生物化学、分子生物学、遗传学、统计学、细胞生物学和药理学方面具有扎实的基础知识，以及一系列以辅导为基础的课程，为学生提供分子药理学方面的高级培训。在头两年的学习中，学生们完成3次实验室轮换，并选择一个实验室进行论文研究。他们在第二年末参加综合的笔试和口试。论文委员会在第一次委员会会议上提出了论文研究的问题和方法后，在第一次委员会会议上审查了拟议的研究。学生们每年都会向MPET教职员工和学生介绍他们的研究项目的最新进展。强烈鼓励学生及时发表已完成的作品，并参加全国会议介绍他们的作品。完成博士课程的平均时间约为4.8年。在第四年和第五年的培训中，指导学生发现优秀的博士后培训机会，作为他们职业发展的下一步。MPET博士培训项目的毕业生有着出色的记录，许多人现在担任首席研究员，指导自己的实验室。